RMAX has already recovered sharply from its 52-week low of $5.46 set in April 2026 to a 52-week high of $13.35 in mid-August. With the stock consolidating just below that high, $15 stands out as the next major psychological threshold. The level has also appeared in public market commentary as a potential recovery objective, even though current published analyst targets generally sit lower.
Because $15 sits above both the 52-week high and the $13.80 per-share merger value, clearing that area would signal that the market sees value beyond the announced transaction—an important distinction for a stock trading with merger-driven dynamics.
RE/MAX Holdings is a franchisor rather than a traditional brokerage owner. It generates revenue through real estate franchise fees and royalties under the RE/MAX brand, mortgage brokerage franchising through Motto Mortgage, loan-processing technology through wemlo, and marketing-fund programs. The company has a global footprint, with roughly 149,000 agents reported in early 2026.
Fundamentals remain mixed. Second-quarter 2026 revenue came in at $68.5 million, below consensus estimates of about $73.5 million, while adjusted earnings per share (EPS) of $0.32 also missed the roughly $0.39 consensus. Adjusted EBITDA of $22.9 million shows the franchise model still generates cash flow, but declining revenue and softer agent counts in the U.S. and Canada illustrate why a larger technology-enabled partner may be needed. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
In late April 2026, The Real Brokerage Inc. (NASDAQ: REAX) agreed to acquire RE/MAX Holdings in a cash-and-stock transaction. Each RMAX shareholder may elect to receive $13.80 in cash or 5.152 shares of the combined company, Real REMAX Group, subject to proration that caps total cash consideration between $60 million and $80 million. The deal is expected to close in the second half of 2026, subject to shareholder, regulatory, and court approvals.
The combined entity would have generated about $2.3 billion in pro forma 2025 revenue and about $157 million in adjusted EBITDA, with management targeting around $30 million in annual cost synergies by 2027. Those economics explain why RMAX has traded toward the $13.80 level—but they also explain why standalone upside above $13.80 is not currently the base case.
RMAX’s most important support zone sits near $12.10–$12.30, an area where the stock consolidated before its most recent push higher. Below that, the $11.30–$11.40 zone represents the early-August breakout area and a more significant demand zone. On the upside, $13.35 is the immediate 52-week high and the clearest near-term resistance. Above that, $13.80 is the merger-implied value, and $15 is the next major psychological target.
A sustained hold above $12.30 would keep the recent uptrend intact, while a decisive break below $11.30 would suggest the merger-related optimism is fading and put the focus back on the lower end of the range. From what I see, monitoring these levels closely helps frame the risk-reward around the $15 scenario.
Can RE/MAX Holdings reach $15? The path exists, but it is more demanding than reaching the $13.80 transaction value. The strongest support comes from the merger, the company’s global franchise network, and the combined entity’s synergy potential. The largest obstacles are the deal-level anchor, softer revenue and earnings momentum, and a real estate industry still adjusting to commission and affordability pressures. Investors should monitor merger closing progress, the implied value of the stock consideration, quarterly agent-count and revenue trends, and whether RMAX can clear $13.35 on a closing basis. Until then, $15 remains a credible stretch scenario rather than the central expectation.
I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to stay on top of stocks like RMAX. The tool uses artificial intelligence to monitor thousands of securities and generate Buy, Sell, or Hold signals based on technical behavior and market conditions. It helps me place short-term price action around the $13.35 and $13.80 resistance levels in a broader, data-driven context without replacing my own analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RMAX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 26, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 37 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 84%.
The 10-day RSI Indicator for RMAX moved out of overbought territory on August 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 17 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 54 cases where RMAX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for RMAX entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on September 08, 2026. You may want to consider a long position or call options on RMAX as a result. In 68 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.463) is normal, around the industry mean (3.390). RMAX has a moderately high P/E Ratio (485.000) as compared to the industry average of (128.859). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (0.672). Dividend Yield (0.019) settles around the average of (0.021) among similar stocks. P/S Ratio (0.909) is also within normal values, averaging (5.571).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of real estate brokerage services
Industry RealEstateDevelopment